Management of asthma patients during the COVID-19 pandemic: pathophysiological considerations to address the challenges

bracu.type.groupResearch Publications
datacite.rightsOpen Access
dc.contributor.authorTabassum, Tahani
dc.contributor.authorRahman, Ahsab
dc.contributor.authorAraf, Yusha
dc.contributor.authorUllah, Md. Asad
dc.contributor.authorHosen, Mohammad Jakir
dc.contributor.departmentDepartment of Mathematics and Natural Sciences
dc.date.accessioned2026-07-19T06:33:59Z
dc.date.available2026-07-19T06:33:59Z
dc.date.issued12/1/2022
dc.description.abstractBackground: The coronavirus disease 2019 (COVID-19) has become a serious global health issue, especially for people with pre-existing health conditions. Patients dealing with asthma are presumed to be at higher risk as COVID-19 may cause severe respiratory distress. Main body: From the initial stage of the pandemic, several clinical trials and studies have assessed the association between COVID-19 and asthma; however, no significant association was reported. This may be due to the fact that most of the asthma cases remained undiagnosed and overlapping respiratory features make it difficult to differentiate between these two diseases. The pathomechanism of the conditions and the immune response generated in response to the conditions suggest that the presence of any of the conditions is very likely to influence the presence or severity of the other condition. So far, no specific treatments are known for COVID-19; however, the use of plasma therapy and broad-spectrum antiviral drugs during the initial phase of the pandemic and widespread vaccination during the latter phase has given positive outcomes in reducing COVID-19 cases as well as disease severity. Short conclusion: Taking asthma as an increased risk factor for COVID-19 morbidity, this article aims to provide comprehensive insights into the risk and proper management of asthma patients during this COVID-19 pandemic. The common medications of asthma patients suppress their respiratory immune response that might facilitate cytokine storm in COVID-19 patients. Similarly, there are risks of viral-induced asthma exacerbations. Besides, different social issues such as shortage of medicines, SDOH, and delayed clinical trials put asthma patients through inconvenience. The primary focus at this point should be to reduce probable asthma attacks and severity to prevent hospitalization of asthma patients. Moreover, for better management of asthma patients maintaining an asthma action plan and healthy lifestyle, ensuring a nutritious diet, and developing self-management interventions can play a crucial role. © 2022, The Author(s).
dc.description.versionPublished
dc.format.extent14 pages
dc.identifier.citationTabassum, T., Rahman, A., Araf, Y. et al. Management of asthma patients during the COVID-19 pandemic: pathophysiological considerations to address the challenges. Beni-Suef Univ J Basic Appl Sci 11, 20 (2022). https://doi.org/10.1186/s43088-022-00204-4
dc.identifier.doi10.1186/s43088-022-00204-4
dc.identifier.issn23148535
dc.identifier.other2-s2.0-85124394812
dc.identifier.urihttps://hdl.handle.net/10361/28593
dc.language.isoen_US
dc.publisherSpringer Science and Business Media Deutschland GmbH
dc.relation.hasversion10.1186/s43088-022-00204-4
dc.relation.ispartofBeni Suef University Journal of Basic and Applied Sciences
dc.relation.ispartofseriesBeni Suef University Journal of Basic and Applied Sciences
dc.relation.journalBeni-Suef University Journal of Basic and Applied Sciences
dc.relation.urihttps://link.springer.com/article/10.1186/s43088-022-00204-4?utm_source=getftr&utm_medium=getftr&utm_campaign=getftr_pilot&getft_integrator=scopus
dc.rightsTRUE
dc.subjectAsthma
dc.subjectCOVID-19
dc.subjectManagement
dc.subjectMedications
dc.subjectPathophysiology
dc.subjectRespiratory distress
dc.subjectRisk
dc.subjectSelf-care
dc.subjectTelehealth
dc.subject.lcshAsthma--Chemotherapy--Complications.
dc.subject.lcshAsthma.
dc.titleManagement of asthma patients during the COVID-19 pandemic: pathophysiological considerations to address the challenges
dc.typeArticle
oaire.citation.issue1
oaire.citation.volume11
person.affiliation.nameBRAC University
person.affiliation.nameBRAC University
person.affiliation.nameShahjalal University of Science and Technology
person.affiliation.nameJahangirnagar University
person.affiliation.nameShahjalal University of Science and Technology
person.identifier.orcid0000-0001-6702-3336
person.identifier.orcid0000-0001-7529-5411
person.identifier.orcid0000-0002-0144-5875
person.identifier.orcid0000-0002-6615-6433
person.identifier.orcid0000-0001-6444-0214
person.identifier.scopus-author-id57223186656
person.identifier.scopus-author-id57216965835
person.identifier.scopus-author-id57216253470
person.identifier.scopus-author-id57216082465
person.identifier.scopus-author-id55809357700

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Management of asthma patients during the COVID-19 pandemic pathophysiological considerations to address the challenges.pdf
Size:
1.18 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: